Tyndall Capital Partners

Tyndall Capital Partners as of Sept. 30, 2016

Portfolio Holdings for Tyndall Capital Partners

Tyndall Capital Partners holds 2 positions in its portfolio as reported in the September 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Onconova Therapeutics 78.8 $1.5M 521k 2.79
Onconova Therapeutics Inc *w exp 07/07/202 21.2 $391k 391k 1.00